Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
-- Once-a-day tablet Daxas(R) (roflumilast) is a first-in-class treatment under development targeting inflammation, the underlying cause of...
NEW YORK, Aug. 10 /PRNewswire-FirstCall/ -- -- Forest Laboratories acquires exclusive commercialisation rights to Daxas in the United...
DALLAS, June 22 /PRNewswire/ -- BeaconEquity.com announces the availability of stock alerts on today's active stocks. Stock alerts highlight...
Data Presented at the 2008 International Conference of the American Thoracic Society TORONTO, May 20 /PRNewswire-FirstCall/ -- Forest...
NEW YORK, Nov. 8 /PRNewswire/ -- Total daily dosages of milnacipran 100 mg and 200 mg demonstrated statistically significant and clinically...
NEW YORK, May 1 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) announced today that its licensing partner Mylan Laboratories...
In the news release, "Forest Laboratories Revises Research and Development Spending Projection to Account for Upfront Payments for Two Recent...
RNS Number:3979H Firth Rixson PLC 12 February 2003 Firth Rixson plc ("the Company") Firth Rixson plc was advised on 11 February 2003 that...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지